Partial Biological Characterization of Cancer Stem-like Cell Line (WJ(2)) of Human Glioblastoma Multiforme

Overview

Journal Cell Mol Neurobiol

Publisher Springer

Specialties Cell Biology
Molecular Biology
Neurology

Date 2008 Mar 20

PMID 18350379

Citations 8

Authors

Jing Wang

Xiujie Wang

Shu Jiang

Ping Lin

Jie Zhang

Yaying Wu

Zhujuan Xiong

Jing Jing Ren

Hongliang Yang

Affiliations

Soon will be listed here.

Abstract

To provide suitable models for human GBM cancer stem cells in vitro and in vivo, and investigate their biological characteristics, a new human GBM cancer stem-like cell line, WJ2, was established in this experiment through serial passages from adherent monolayer culture to nonadherent tumor sphere culture in turns; Its partial biological characteristics were studied through cell proliferation and tumor sphere assay; cell cycle distribution, side population, and CD133 phenotype were analyzed with FCM. The expressions of CD133, Nestin, and GFAP of cancer stem-like cells and xenograft tumor cells were detected with RT-PCR and immunohistochemistry. Biological characterization, side population, CD133 phenotype and CD133 Nestin, BCRP-1, Wnt-1 gene expression revealed the stemness of this cancer stem-like cell line. Tumorigenicity heterotransplanted in nude mice; histopathological characteristics of xenograft tumor, and expressions of CD133, Nestin, and GFAP of xenograft tumor cells indicated that xenograft tumors recapitulated the phenotype and biological characterization of human primary GBM. All findings of this experimental study suggested that WJ(2) cancer stem-like cell line could accurately mimic human GBM cancer stem cell in vitro and in vivo; it would be useful in the cellular and molecular studies as well as in testing novel therapies of CSC-based anti-cancer therapies for human GBM.

Citing Articles

Glioblastoma Stem Cell-Derived Exosomes Enhance Stemness and Tumorigenicity of Glioma Cells by Transferring Notch1 Protein.

Sun Z, Wang L, Zhou Y, Dong L, Ma W, Lv L Cell Mol Neurobiol. 2019; 40(5):767-784.

PMID: 31853695 PMC: 11448788. DOI: 10.1007/s10571-019-00771-8.

Biomimetic brain tumor niche regulates glioblastoma cells towards a cancer stem cell phenotype.

Liu Y, Lee I, Chen P J Neurooncol. 2018; 137(3):511-522.

PMID: 29357090 DOI: 10.1007/s11060-018-2763-2.

Establishment and Biological Characterization of a Panel of Glioblastoma Multiforme (GBM) and GBM Variant Oncosphere Cell Lines.

Binder Z, Wilson K, Salmasi V, Orr B, Eberhart C, Siu I PLoS One. 2016; 11(3):e0150271.

PMID: 27028405 PMC: 4814135. DOI: 10.1371/journal.pone.0150271.

Polycomb group gene BMI1 controls invasion of medulloblastoma cells and inhibits BMP-regulated cell adhesion.

Merve A, Dubuc A, Zhang X, Remke M, Baxter P, Li X Acta Neuropathol Commun. 2014; 2:10.

PMID: 24460684 PMC: 3928978. DOI: 10.1186/2051-5960-2-10.

TRAIL and paclitaxel synergize to kill U87 cells and U87-derived stem-like cells in vitro.

Qiu B, Sun X, Zhang D, Wang Y, Tao J, Ou S Int J Mol Sci. 2012; 13(7):9142-9156.

PMID: 22942757 PMC: 3430288. DOI: 10.3390/ijms13079142.

References

Tropepe V, Sibilia M, Ciruna B, Rossant J, Wagner E, van der Kooy D . Distinct neural stem cells proliferate in response to EGF and FGF in the developing mouse telencephalon. Dev Biol. 1999; 208(1):166-88. DOI: 10.1006/dbio.1998.9192. View

Zheng X, Shen G, Yang X, Liu W . Most C6 cells are cancer stem cells: evidence from clonal and population analyses. Cancer Res. 2007; 67(8):3691-7. DOI: 10.1158/0008-5472.CAN-06-3912. View

Hill R, Perris R . "Destemming" cancer stem cells. J Natl Cancer Inst. 2007; 99(19):1435-40. DOI: 10.1093/jnci/djm136. View

Al-Hajj M . Cancer stem cells and oncology therapeutics. Curr Opin Oncol. 2006; 19(1):61-4. DOI: 10.1097/CCO.0b013e328011a8d6. View

Bar E, Chaudhry A, Lin A, Fan X, Schreck K, Matsui W . Cyclopamine-mediated hedgehog pathway inhibition depletes stem-like cancer cells in glioblastoma. Stem Cells. 2007; 25(10):2524-33. PMC: 2610257. DOI: 10.1634/stemcells.2007-0166. View

Ieta K, Tanaka F, Haraguchi N, Kita Y, Sakashita H, Mimori K . Biological and genetic characteristics of tumor-initiating cells in colon cancer. Ann Surg Oncol. 2007; 15(2):638-48. DOI: 10.1245/s10434-007-9605-3. View

OBrien C, Pollett A, Gallinger S, Dick J . A human colon cancer cell capable of initiating tumour growth in immunodeficient mice. Nature. 2006; 445(7123):106-10. DOI: 10.1038/nature05372. View

Piccirillo S, Vescovi A . Bone morphogenetic proteins regulate tumorigenicity in human glioblastoma stem cells. Ernst Schering Found Symp Proc. 2007; (5):59-81. DOI: 10.1007/2789_2007_044. View

Yin S, Li J, Hu C, Chen X, Yao M, Yan M . CD133 positive hepatocellular carcinoma cells possess high capacity for tumorigenicity. Int J Cancer. 2007; 120(7):1444-50. DOI: 10.1002/ijc.22476. View

10.

Zhou J, Wulfkuhle J, Zhang H, Gu P, Yang Y, Deng J . Activation of the PTEN/mTOR/STAT3 pathway in breast cancer stem-like cells is required for viability and maintenance. Proc Natl Acad Sci U S A. 2007; 104(41):16158-63. PMC: 2042178. DOI: 10.1073/pnas.0702596104. View

11.

Wang J, Wang X, Jiang S, Lin P, Zhang J, Wu Y . Establishment of a new human glioblastoma multiforme cell line (WJ1) and its partial characterization. Cell Mol Neurobiol. 2007; 27(7):831-43. PMC: 11517347. DOI: 10.1007/s10571-007-9188-3. View

12.

Panagiotakos G, Tabar V . Brain tumor stem cells. Curr Neurol Neurosci Rep. 2007; 7(3):215-20. DOI: 10.1007/s11910-007-0033-3. View

13.

Gal H, Makovitzki A, Amariglio N, Rechavi G, Ram Z, Givol D . A rapid assay for drug sensitivity of glioblastoma stem cells. Biochem Biophys Res Commun. 2007; 358(3):908-13. DOI: 10.1016/j.bbrc.2007.05.020. View

14.

Serakinci N, Erzik C . Road for understanding cancer stem cells: model cell lines. Regen Med. 2007; 2(6):957-65. DOI: 10.2217/17460751.2.6.957. View

15.

Sakariassen P, Immervoll H, Chekenya M . Cancer stem cells as mediators of treatment resistance in brain tumors: status and controversies. Neoplasia. 2007; 9(11):882-92. PMC: 2077879. DOI: 10.1593/neo.07658. View

16.

Fan X, Salford L, Widegren B . Glioma stem cells: evidence and limitation. Semin Cancer Biol. 2006; 17(3):214-8. DOI: 10.1016/j.semcancer.2006.04.002. View

17.

Pfenninger C, Roschupkina T, Hertwig F, Kottwitz D, Englund E, Bengzon J . CD133 is not present on neurogenic astrocytes in the adult subventricular zone, but on embryonic neural stem cells, ependymal cells, and glioblastoma cells. Cancer Res. 2007; 67(12):5727-36. DOI: 10.1158/0008-5472.CAN-07-0183. View

18.

Lee J, Kotliarova S, Kotliarov Y, Li A, Su Q, Donin N . Tumor stem cells derived from glioblastomas cultured in bFGF and EGF more closely mirror the phenotype and genotype of primary tumors than do serum-cultured cell lines. Cancer Cell. 2006; 9(5):391-403. DOI: 10.1016/j.ccr.2006.03.030. View

19.

Seigel G, Hackam A, Ganguly A, Mandell L, Gonzalez-Fernandez F . Human embryonic and neuronal stem cell markers in retinoblastoma. Mol Vis. 2007; 13:823-32. PMC: 2768758. View

20.

Singh S, Clarke I, Terasaki M, Bonn V, Hawkins C, Squire J . Identification of a cancer stem cell in human brain tumors. Cancer Res. 2003; 63(18):5821-8. View